Inflammatory cytokines and cell response in surgery

Spink, 1997, Synergy and specificity in induction of gene activity by proinflammatory cytokines: potential therapeutic targets, Shock, 7, 405, 10.1097/00024382-199706000-00002

Guirao, 1996, Biologic control of injury and inflammation: Much more than too little or too late, World J Surg, 20, 437, 10.1007/s002689900069

Lin, 1998, The human response to endotoxin, Sepsis, 2, 255, 10.1023/A:1009890031293

Van Berge Henegouwen, 1998, Peritoneal cytokine release after elective gastrointestinal surgery and postoperative complications, Am J Surg, 175, 311, 10.1016/S0002-9610(98)00010-5

Lin, 1998, Cytokine response in abdominal surgery, 17

Enayati, 1994, Systemic and liver cytokine activation, Arch Surg, 124, 1159, 10.1001/archsurg.1994.01420350057006

Van der Poll, 1995, Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense?, Shock, 3, 1

Van der Poll, 1995, Endogenous mechanisms regulating TNF and IL-1 during sepsis, 385

Dinarello, 1991, Interleukin-1 and interleukin-1 antagonism, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627

Fong, 1996, Cytokines and the cellular response to injury and infection, 15, 1

Schafer, 1994, Interleukin-1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in immune tissue, Proc Natl Acad Sci USA, 91, 4219, 10.1073/pnas.91.10.4219

Ohlsson, 1990, Interleukin-1 receptor antagonist reduces mortality from endotoxic shock, Nature, 348, 550, 10.1038/348550a0

Abraham, 1983, The effects of hemorrhage and trauma on interleukin-2 production, Arch Surg, 120, 1341, 10.1001/archsurg.1985.01390360007002

Oka, 1996, Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress, Ann Surg, 223, 434, 10.1097/00000658-199604000-00013

Keegan, 1996, IL-4 regulates growth and differentiation by distinct mechanisms, The Immunologist, 4, 194

Mangan, 1991, Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and proinfiammatory cytokines, J Immunol, 147, 3408, 10.4049/jimmunol.147.10.3408

Xing, 1998, IL-6 is an antiinfiammatory cytokine required for controlling local or systemic acute inflammatory responses, J Clin Invest, 101, 311, 10.1172/JCI1368

Biffl, 1996, Interleukin-6 delays neutrophil apoptosis, Arch Surg, 131, 24, 10.1001/archsurg.1996.01430130026005

Tilg, 1994, Interleukin-6 (IL-6) as an antiinfiammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55, Blood, 83, 113, 10.1182/blood.V83.1.113.113

Patrick, 1996, The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure, Am J Surg, 172, 425, 10.1016/S0002-9610(96)00252-8

Van Zee, 1992, Effects of intravenous IL-8 administration in nonhuman primates, J Immunol, 148, 1746, 10.4049/jimmunol.148.6.1746

Gerard, 1993, Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia, J Exp Med, 177, 547, 10.1084/jem.177.2.547

Marshall, 1999, Regulation of human IL-18 mRNA expression, Clin Immunol, 90, 15, 10.1006/clim.1998.4633

Van der Poll, 1995, Endogenous IL-10 protects mice from death during septic peritonitis, J Immunol, 155, 5397, 10.4049/jimmunol.155.11.5397

Steibhauser, 1999, Multiple roles for IL-12 in a model of acute septic peritonitis, J Immunol, 162, 5437, 10.4049/jimmunol.162.9.5437

Lauw, 1999, Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees, J Infect Dis, 179, 646, 10.1086/314636

Carson, 1999, A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells, J Immunol, 162, 4943, 10.4049/jimmunol.162.8.4943

Chomarat, 1998, Interleukin-4 and interleukin-13: their similarities and discrepancies, Int Rev Immunol, 17, 1, 10.3109/08830189809084486

Manna, 1998, Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-l, and c-Jun N-terminal kinase: comparison with interleukin-13, J Biol Chem, 273, 33333, 10.1074/jbc.273.50.33333

Etter, 1998, IL-4 and IL-13 downregulate rolling adhesion of leukocytes to IL-1 or TNF-alpha-activated endothelial cells by limiting the interval of E-selectin expression, Cytokine, 10, 395, 10.1006/cyto.1997.0308

Alleva, 1997, IL-15 functions as a potent autocrine regulator of macrophage proinfiammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition, J Immunol, 159, 2941, 10.4049/jimmunol.159.6.2941

Bulfone-Paus, 1997, Interleukin-15 protects from lethal apoptosis in vivo, Nat Med, 3, 1124, 10.1038/nm1097-1124

McDonald, 1998, Interleukin-15 (IL-15) induces NF-kappaB activation and IL-8 production in human neutrophils, Blood, 92, 4828, 10.1182/blood.V92.12.4828

Musso, 1998, Interleukin-15 activates proinfiammatory and antimicrobial functions in polymorphonuclear cells, Infect Immun, 66, 2640, 10.1128/IAI.66.6.2640-2647.1998

Puren, 1999, Gene expression, synthesis, and secretion of interleukin-18 and interleukin-1β are differentially regulated in human blood mononuclear cells and mouse spleen cells, Proc Natl Acad Sci USA, 96, 2256, 10.1073/pnas.96.5.2256

Bohn, 1998, IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice, J Immunol, 160, 299, 10.4049/jimmunol.160.1.299

Hoshino, 1999, Generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor, J Immunol, 162, 5041, 10.4049/jimmunol.162.9.5041

Kohka, 1998, Interleukin-18/interferon-γ-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells, J Leukoc Biol, 64, 519, 10.1002/jlb.64.4.519

Tsutsui, 1997, IL-18 accounts for both TNF-α- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice, J Immunol, 159, 3961, 10.4049/jimmunol.159.8.3961

Oberholzer, 1998, Increased circulating levels of interleukin-18 during severe sepsis in humans, Surg Forum, 49, 88

Heinzel, 1994, Interleukin-12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon, Infect Immunol, 62, 4244, 10.1128/IAI.62.10.4244-4249.1994

Dinarello, 1999, IL-18: A THl-inducing, proinflammatory cytokine and new member of the IL-1 family, J Allergy Clin Immunol, 103, 11, 10.1016/S0091-6749(99)70518-X

Barbul, 1990, The regulatory role of T lymphocytes in wound healing, J Trauma, 30, S97, 10.1097/00005373-199012001-00021

Keel, 1997, Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis, Blood, 90, 3356, 10.1182/blood.V90.9.3356

Ertel, 1998, Circulating mediators in serum of injured patients with septic complications inhibit neutrophil apoptosis through upregulation of protein-tyrosine phosphorylation, J Trauma, 44, 767, 10.1097/00005373-199805000-00005

Fanning, 1999, Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation, Shock, 11, 167, 10.1097/00024382-199903000-00003

Decker, 1996, Surgical stress induces a shift in the type-I/type-2 T helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma, Surgery, 119, 316, 10.1016/S0039-6060(96)80118-8

Lin, 1999, The systemic response to injury, 3

Zedler, 1999, T-cell reactivity and its predictive role in immunosuppression after burns, Crit Care Med, 27, 66, 10.1097/00003246-199901000-00028

Berguer, 1999, Major surgery suppresses maximal production of helper T-cell type 1 cytokines without potentiating the release of helper T-cell type 2 cytokines, Arch Surg, 134, 540, 10.1001/archsurg.134.5.540

Lin, 1997, Disordered apoptosis as a mechanism for adverse outcome in critical illness, 91

Lin, 1997, The biologic control of systemic inflammatory response, Curr Opin Crit Care, 3, 299, 10.1097/00075198-199708000-00009

Ksontini, 1998, Revisiting the role of tumor necrosis factor α and the response to surgical injury and inflammation, Arch Surg, 133, 558, 10.1001/archsurg.133.5.558

Van Zee, 1994, A human tumor necrosis factor (TNF) α mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon, J Exp Med, 179, 1185, 10.1084/jem.179.4.1185

Welborn, 1996, A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon, J Exp Med, 184, 165, 10.1084/jem.184.1.165

Weiss, 1998, Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80, J Immunol, 158, 2398, 10.4049/jimmunol.158.5.2398

Liu, 1996, Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-κB activation prevents cell death, Cell, 87, 565, 10.1016/S0092-8674(00)81375-6

Anrather, 1997, Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-κB, J Clin Invest, 99, 763, 10.1172/JCI119222

Bohrer, 1997, The role of NF-κB in the mortality of sepsis, J Clin Invest, 100, 972, 10.1172/JCI119648

Zong, 1999, The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNF-α-induced apoptosis, Genes Dev, 13, 382, 10.1101/gad.13.4.382

Moulding, 1998, Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival, Blood, 92, 2495, 10.1182/blood.V92.7.2495

Wissink, 1998, A dual mechanism mediates repression of NF-κB activity by glucocorticoids, Mol Endocrinol, 12, 355

Brostjan, 1997, Glucocorticoids inhibit E-selectin expression by targeting NF-κB and not ATF/c-Jun, J Immunol, 158, 3836, 10.4049/jimmunol.158.8.3836

Ayala, 1995, The induction of accelerated thymic programmed cell death during polymicrobial sepsis: control by corticosteroids but not tumor necrosis factor, Shock, 3, 259, 10.1097/00024382-199504000-00003

Zubiaga, 1992, IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis, J Immunol, 149, 107, 10.4049/jimmunol.149.1.107

Liles, 1995, Glucocorticoids inhibit apoptosis of human neutrophils, Blood, 86, 3181, 10.1182/blood.V86.8.3181.3181

Barber, 1993, Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man, J Immunol, 150, 1999, 10.4049/jimmunol.150.5.1999

Van der Poll, 1996, Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia—a clinical research center study, J Clin Endocrinol Metab, 3604

Kawamura, 1999, Influence of methylprednisolone on cytokine balance during cardiac surgery, Crit Care Med, 27, 545, 10.1097/00003246-199903000-00033

Van der Poll, 1997, Epinephrine inhibits endotoxin-induced IL-1β production: roles of tumor necrosis factor-α and IL-10, Am J Physiol, 273, R1885

Van der Poll, 1997, Lipopolysaccharide-induced interleukin-8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone, Infect Immun, 65, 2378, 10.1128/IAI.65.6.2378-2381.1997

Van der Poll, 1996, Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin-10 production during human endotoxemia, J Clin Invest, 97, 713, 10.1172/JCI118469

Lin, 1999, Tumor necrosis factor receptors in systemic inflammation